{
    "nct_id": "NCT04922307",
    "official_title": "Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer",
    "inclusion_criteria": "* Renal masses ≥ cT2 (by any conventional imaging).\n* N1 or M1 disease is allowed if they are deemed surgical candidates (including cytoreductive nephrectomy).\n* Male and female patients.\n* 18 and older.\n* Ejection fraction (EF) ≥ 45% by echocardiogram (ECHO).\n* Adequate organ function as defined by:\n\n  * Hemoglobin ≥ 9 g/dL. Pre-operative allogenic blood transfusion is allowed.\n  * Platelets ≥ 100.000/μl.\n  * Albumin ≥ 2.5 g/dL.\n  * Aspartate Aminotransferase (AST) and alanine transaminase (ALT) ≤ 75U/L or total bilirubin ≤ 2.0 mg/dL.\n  * WBC within institutional normal limits.\n  * PT within institutional normal limits.\n  * INR < 1.5 and PTT normal.\n  * Consent and compliance with all aspects of the study protocol.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Male and female younger than 18 years old.\n* Non-surgical candidate\n* Unstable angina.",
    "miscellaneous_criteria": ""
}